Bio-Techne Corp
TECH: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| jp | LOCK|>!>c | LOCK|$$&@h@H |
Bio-Techne: Acquisition by Merck KGaA Still on Track For Late 2026 or Early 2027 Close
Bio-Techne's acquisition by Merck KGaA, announced June 25, 2026, remains on track to close by late 2026 or early 2027. After clearing Germany's antitrust review on Aug. 17 and US antitrust review on Sept. 18, Bio-Techne shareholders approved the merger on Sept. 23.
